Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Tirzepatide is a newer dual GLP-1/GIP agonist that targets two receptors simultaneously, and clinical data has demonstrated even greater average weight loss compared to single-receptor medications
Most dosing confusion starts right here, with patients assuming all semaglutide vials work the same way
PlexusDx supports precision-informed conversations with providers about continuous vs
Patients can access Ozempic, Wegovy, Mounjaro, Zepbound, and Saxenda depending on insurance coverage and clinical appropriateness
HSA and FSA funds are accepted, making medication more accessible for many patients
US$ 21.92
US$ 28.52
US$ 21.88
US$ 27.04
US$ 21.18
